吉利德与卫材达成协议:在日本共同推广非洛替尼(Filgotinib)治疗类风湿性关节炎

2019-12-27 Allan MedSci原创

吉利德与卫材近日宣布,双方已经达成协议,在日本共同推广选择性JAK1抑制剂非洛替尼(filgotinib),用于治疗类风湿性关节炎(RA)。

吉利德与卫材近日宣布,双方已经达成协议,在日本共同推广选择性JAK1抑制剂非洛替尼(filgotinib),用于治疗类风湿性关节炎(RA)。如果获得批准,两家公司将共同对非洛替尼(Filgotinib)进行商业化。

全日本大约有60万至100万人患有RA,尽管有可用的选择,但许多人仍未经历疾病缓解。在全球FINCH III期研究中,filgotinib在多个RA患者人群中显示了持久的疗效和安全性结果,包括先前对甲氨蝶呤治疗(MTX)反应不佳的患者、对一种或多种生物疗法不耐受的患者以及初治患者。


原始出处:

http://www.firstwordpharma.com/node/1689714?tsid=4#axzz69CnI0iLA

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1266079, encodeId=07ce12660e9e2, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469352, encodeId=82931469352f3, content=<a href='/topic/show?id=d5ede4469b' target=_blank style='color:#2F92EE;'>#Filgotinib#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7446, encryptionId=d5ede4469b, topicName=Filgotinib)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91457016663, createdName=xirongguo, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483641, encodeId=b7a0148364103, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587400, encodeId=8f84158e40002, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
    2019-12-29 lmm397
  2. [GetPortalCommentsPageByObjectIdResponse(id=1266079, encodeId=07ce12660e9e2, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469352, encodeId=82931469352f3, content=<a href='/topic/show?id=d5ede4469b' target=_blank style='color:#2F92EE;'>#Filgotinib#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7446, encryptionId=d5ede4469b, topicName=Filgotinib)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91457016663, createdName=xirongguo, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483641, encodeId=b7a0148364103, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587400, encodeId=8f84158e40002, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1266079, encodeId=07ce12660e9e2, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469352, encodeId=82931469352f3, content=<a href='/topic/show?id=d5ede4469b' target=_blank style='color:#2F92EE;'>#Filgotinib#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7446, encryptionId=d5ede4469b, topicName=Filgotinib)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91457016663, createdName=xirongguo, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483641, encodeId=b7a0148364103, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587400, encodeId=8f84158e40002, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1266079, encodeId=07ce12660e9e2, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469352, encodeId=82931469352f3, content=<a href='/topic/show?id=d5ede4469b' target=_blank style='color:#2F92EE;'>#Filgotinib#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7446, encryptionId=d5ede4469b, topicName=Filgotinib)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91457016663, createdName=xirongguo, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483641, encodeId=b7a0148364103, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587400, encodeId=8f84158e40002, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1266079, encodeId=07ce12660e9e2, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469352, encodeId=82931469352f3, content=<a href='/topic/show?id=d5ede4469b' target=_blank style='color:#2F92EE;'>#Filgotinib#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7446, encryptionId=d5ede4469b, topicName=Filgotinib)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91457016663, createdName=xirongguo, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483641, encodeId=b7a0148364103, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587400, encodeId=8f84158e40002, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1266079, encodeId=07ce12660e9e2, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469352, encodeId=82931469352f3, content=<a href='/topic/show?id=d5ede4469b' target=_blank style='color:#2F92EE;'>#Filgotinib#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7446, encryptionId=d5ede4469b, topicName=Filgotinib)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91457016663, createdName=xirongguo, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483641, encodeId=b7a0148364103, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587400, encodeId=8f84158e40002, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1266079, encodeId=07ce12660e9e2, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294516, encodeId=6828129451680, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334190, encodeId=38a51334190f2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76164, encryptionId=5306e6164b6, topicName=类风湿)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq2AGzrugK9ZUjU3eJxzM901ophWib0xJDrSicy49ibWl3zB5pbDto7eoR6tnzwOiaKdbq1a8PcbYFFrw/132, createdBy=6ff22500098, createdName=ms4964546379600229, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36581, encryptionId=72233658193, topicName=卫材)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de215370353, createdName=yyanpro@23cn.c, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469352, encodeId=82931469352f3, content=<a href='/topic/show?id=d5ede4469b' target=_blank style='color:#2F92EE;'>#Filgotinib#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7446, encryptionId=d5ede4469b, topicName=Filgotinib)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91457016663, createdName=xirongguo, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1483641, encodeId=b7a0148364103, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100826, encryptionId=55a6100826cc, topicName=风湿性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c237911872, createdName=ms1467340776200723, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587400, encodeId=8f84158e40002, content=<a href='/topic/show?id=7e9a56e67a0' target=_blank style='color:#2F92EE;'>#推广#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56767, encryptionId=7e9a56e67a0, topicName=推广)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dff417466583, createdName=zhangxingru, createdTime=Sun Dec 29 08:08:00 CST 2019, time=2019-12-29, status=1, ipAttribution=)]

相关资讯

吉利德的JAK1抑制剂filgotinib治疗类风湿性关节炎III期临床成功

吉利德(Gilead)宣布,其JAK1抑制剂filgotinib在一项评估其治疗中度至重度活跃性类风湿性关节炎(RA)的疗效和安全性的III期试验中被证明是成功的。

Lancet:好消息!Filgotinib可使中重度Crohn病患者临床缓解

filgotinib相比于安慰剂能更好地诱导活动的Crohn病患者达到临床缓解,并且具有可接受的安全性。

JAMA:Filgotinib治疗难治性活动性类风湿关节炎

研究认为,对于先前接受BDMARD 后疗效不充分或不耐受的活动性类风湿关节炎患者,Filgotinib治疗在第12周达到临床反应的比例显著增加。然而,需要进一步的研究来评估长期疗效和安全性